PALMIDROL

Search structure
Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 6R8T1UDM3V

Structure
InChI Key HXYVTAGFYLMHSO-UHFFFAOYSA-N
Smile CCCCCCCCCCCCCCCC(=O)NCCO
InChI
InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h20H,2-17H2,1H3,(H,19,21)

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H37NO2
Molecular Weight 299.5
AlogP 4.58
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 16.0
Polar Surface Area 49.33
Molecular species NEUTRAL
Aromatic Rings 0.0
Heavy Atoms 21.0

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Hydrolase
- 5011.87 - - 49-68
Enzyme Transferase
- - - - 3.157-24.17
Epigenetic regulator Eraser Histone deacetylase HDAC class IIb
- - - - -0.28-7.03
Membrane receptor Family A G protein-coupled receptor Small molecule receptor (family A GPCR) Lipid-like ligand receptor (family A GPCR) Cannabinoid receptor
- - - - 13.9-14

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Migraine Disorders 3 D008881 ClinicalTrials
Mastocytosis 2 D008415 ClinicalTrials
Bipolar Disorder 2 D001714 ClinicalTrials
Tourette Syndrome 2 D005879 ClinicalTrials
Severe Acute Respiratory Syndrome 2 D045169 ClinicalTrials
Chronic Pain 2 D059350 ClinicalTrials
Opioid-Related Disorders 1 D009293 ClinicalTrials

Cross References

Resources Reference
ChEBI 71464
ChEMBL CHEMBL417675
DrugBank DB14043
DrugCentral 2045
EPA CompTox DTXSID4042254
FDA SRS 6R8T1UDM3V
Human Metabolome Database HMDB0002100
Guide to Pharmacology 3622
KEGG C16512
PubChem 4671
SureChEMBL SCHEMBL120518
ZINC ZINC000008035017
CONTENTS